221 related articles for article (PubMed ID: 15857578)
1. The role of epigenetic inactivation of 14-3-3sigma in human cancer.
Lodygin D; Hermeking H
Cell Res; 2005 Apr; 15(4):237-46. PubMed ID: 15857578
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.
Lodygin D; Diebold J; Hermeking H
Oncogene; 2004 Dec; 23(56):9034-41. PubMed ID: 15489902
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of 14-3-3sigma in cancer.
Lodygin D; Hermeking H
Semin Cancer Biol; 2006 Jun; 16(3):214-24. PubMed ID: 16698281
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3sigma is down-regulated in human prostate cancer.
Urano T; Takahashi S; Suzuki T; Fujimura T; Fujita M; Kumagai J; Horie-Inoue K; Sasano H; Kitamura T; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2004 Jul; 319(3):795-800. PubMed ID: 15184053
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M
Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910
[TBL] [Abstract][Full Text] [Related]
6. Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.
Osada H; Tatematsu Y; Yatabe Y; Nakagawa T; Konishi H; Harano T; Tezel E; Takada M; Takahashi T
Oncogene; 2002 Apr; 21(15):2418-24. PubMed ID: 11948426
[TBL] [Abstract][Full Text] [Related]
7. 14-3-3 proteins--an update.
Mhawech P
Cell Res; 2005 Apr; 15(4):228-36. PubMed ID: 15857577
[TBL] [Abstract][Full Text] [Related]
8. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
9. [The roles of DNA methylation in human neoplasms].
Yuan YF; Li JQ; Yang ZL; Wang JP
Ai Zheng; 2002 Nov; 21(11):1267-77. PubMed ID: 12526230
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of 14-3-3sigma by hypermethylation is a rare event in colorectal cancers and its expression may correlate with cell cycle maintenance at the invasion front.
Ide M; Nakajima T; Asao T; Kuwano H
Cancer Lett; 2004 Apr; 207(2):241-9. PubMed ID: 15072834
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma.
Lodygin D; Yazdi AS; Sander CA; Herzinger T; Hermeking H
Oncogene; 2003 Aug; 22(35):5519-24. PubMed ID: 12934112
[TBL] [Abstract][Full Text] [Related]
12. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
13. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.
Kaneuchi M; Sasaki M; Tanaka Y; Shiina H; Verma M; Ebina Y; Nomura E; Yamamoto R; Sakuragi N; Dahiya R
Biochem Biophys Res Commun; 2004 Apr; 316(4):1156-62. PubMed ID: 15044106
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers.
Suzuki H; Itoh F; Toyota M; Kikuchi T; Kakiuchi H; Imai K
Cancer Res; 2000 Aug; 60(16):4353-7. PubMed ID: 10969776
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation patterns of the CDH1, RARB, and SFN genes in choroid plexus tumors.
Losi-Guembarovski R; Kuasne H; Guembarovski AL; Rainho CA; Cólus IM
Cancer Genet Cytogenet; 2007 Dec; 179(2):140-5. PubMed ID: 18036402
[TBL] [Abstract][Full Text] [Related]
16. Gene silencing by DNA methylation in haematological malignancies.
Boultwood J; Wainscoat JS
Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic changes in cancer and preneoplasia.
Herman JG
Cold Spring Harb Symp Quant Biol; 2005; 70():329-33. PubMed ID: 16869769
[TBL] [Abstract][Full Text] [Related]
18. [14-3-3sigma (stratifin), a potential tumor suppressor frequently inactivated by methylation in cancer of the breast].
Jeanteur P
Bull Cancer; 2000 Jul; 87(7-8):525. PubMed ID: 10969206
[No Abstract] [Full Text] [Related]
19. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma.
Yi B; Tan SX; Tang CE; Huang WG; Cheng AL; Li C; Zhang PF; Li MY; Li JL; Yi H; Peng F; Chen ZC; Xiao ZQ
J Cell Biochem; 2009 Apr; 106(5):858-66. PubMed ID: 19160382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
